ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 130 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $307,000 | +24.8% | 6,703 | +37.0% | 0.00% | – |
Q2 2020 | $246,000 | -53.5% | 4,891 | -44.4% | 0.00% | -100.0% |
Q3 2019 | $529,000 | -84.9% | 8,797 | -78.9% | 0.00% | -85.7% |
Q2 2019 | $3,513,000 | +45.8% | 41,635 | +65.0% | 0.01% | +40.0% |
Q1 2019 | $2,410,000 | +50.9% | 25,234 | +11.9% | 0.01% | +25.0% |
Q4 2018 | $1,597,000 | -60.5% | 22,553 | -52.3% | 0.00% | -50.0% |
Q3 2018 | $4,044,000 | -49.6% | 47,319 | -31.7% | 0.01% | -52.9% |
Q2 2018 | $8,029,000 | +456.4% | 69,276 | +41.0% | 0.02% | +240.0% |
Q1 2016 | $1,443,000 | +5.0% | 49,119 | +18.0% | 0.01% | +25.0% |
Q4 2015 | $1,374,000 | – | 41,623 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |